PGIM Jennison Health Sciences R (PJHRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
32.60
-0.09 (-0.28%)
At close: Dec 26, 2025
4.02%
Fund Assets1.56B
Expense Ratio1.48%
Min. Investment$0.00
Turnover79.00%
Dividend (ttm)5.00
Dividend Yield15.52%
Dividend Growth-3.85%
Payout FrequencyAnnual
Ex-Dividend DateDec 19, 2025
Previous Close32.69
YTD Return20.46%
1-Year Return20.38%
5-Year Return37.62%
52-Week Low23.53
52-Week High32.96
Beta (5Y)n/a
Holdings51
Inception DateFeb 3, 2012

About PJHRX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on achieving long-term capital appreciation by predominantly investing in companies within the healthcare, biotech, and pharmaceutical sectors. This fund targets equity-related securities of U.S. firms involved in industries such as hospitals, health insurance providers, pharmaceutical companies, and medical equipment manufacturers. By concentrating on these sectors, the fund provides a strategic investment opportunity for those interested in the healthcare and biotechnology industries. The fund's high-conviction approach is managed by experienced healthcare specialists, making it a notable player in the financial market for investors seeking exposure to these rapidly evolving sectors.

Fund Family PGIM Investments
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol PJHRX
Share Class Class R
Index S&P Composite 1500 Health Care TR

Performance

PJHRX had a total return of 20.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 23.76%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PHLAXClass A1.13%
PHLCXClass C1.96%

Top 10 Holdings

51.23% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY16.48%
Thermo Fisher Scientific Inc.TMO5.39%
Prudential Govt Money Mkt Fdn/a5.30%
Danaher CorporationDHR5.01%
argenx SEARGX4.62%
UCB SAUCB3.14%
Vertex Pharmaceuticals IncorporatedVRTX2.91%
Neurocrine Biosciences, Inc.NBIX2.90%
AstraZeneca PLCAZN2.80%
UnitedHealth Group IncorporatedUNH2.68%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 19, 2025$5.00136Dec 19, 2025
Dec 20, 2024$5.20167Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Full Dividend History